Takashi Shinzato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takashi Shinzato has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Tadahiro Yonaha
Department of General Internal Medicine, Nakagami Hospital, Okinawa, JPN
3 shared publications- Akihiro Ito
Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki, Okayama 710-8602, Japan
1 shared publication Akihito Okazaki
Department of Respiratory Medicine, Koseiren Takaoka Hospital, 5-10 Eirakumachi, Takaoka, Toyama 933-8555, Japan
1 shared publicationAyano Nakamura
Division of Medical Residency Program, Nakagami Hospital, Okinawa, JPN
1 shared publication- Futoshi Higa
Department of Internal Medicine, National Hospital Organization Okinawa Hospital, 3-20-14 Ganeko, Ginowan, Okinawa 901-2214, Japan
1 shared publication Haruka Ishiki
Department of Infectious Diseases, Nakagami Hospital, 610 Noborikawa, Okinawa-shi, Okinawa 904-2195, Japan
1 shared publication
Latest Publications
- Open Access
- 16 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3) , e105350
Timing of Biliary Drainage and Clinical Outcomes in Acute Cholangitis: A Single-Center Retrospective Cohort Study
Background and aims: Although guidelines recommend early biliary drainage for acute cholangitis, evidence for optimal timing across severity grades remains limited. We examined associations between drainage timing and both functional and survival outcomes stratified by disease severity using the Tokyo Guidelines 2018 criteria. Methods: This retrospective observational cohort study included 214 consecutive patients with acute cholangitis who underwent endoscopic retrograde cholangiopancreatography between April 2022 and March 2024 at a tertiary center in Okinawa, Japan. Patients were classified according to the 2018 Tokyo Guidelines severity criteria. The primary outcome was discharge disposition (favorable: discharge to pre-admission residence; unfavorable: alternative facility or death). Time from presentation to drainage was analyzed at 12-, 24-, 36-, and 48-hour cutoffs using Fisher's exact test. Results: The cohort comprised 92 Grade I (43%), 83 Grade II (39%), and 39 Grade III (18%) patients. Discharge-to-pre-admission-residence rates were 95% (87/92), 80% (66/83), and 69% (27/39), respectively. For Grade I, drainage within 24 hours was associated with 100% (59/59) discharge to pre-admission residence versus 88% (28/32) beyond 24 hours (P = 0.013). Grade II showed no functional benefit but was associated with improved survival when drainage occurred within 48 hours (99% vs 82%, P = 0.045). Grade III survivors showed better functional recovery with drainage within 24 hours (92% vs 50%, P = 0.014), though this comparison included only 10 patients in the delayed group and should be interpreted with considerable caution. Conclusions: Associations between drainage timing and outcomes varied by severity grade and outcome type. Given the observational design and limited adjustment for confounders, these findings suggest severity-stratified drainage protocols may be beneficial but require validation through prospective studies with multivariable adjustment to establish causality.
- 16 March 2026
- Published by Springer Nature in Cureus
- Vol. 18 (3) , e105350
Open AccessTiming of Biliary Drainage and Clinical Outcomes in Acute Cholangitis: A Single-Center Retrospective Cohort Study
Background and aims: Although guidelines recommend early biliary drainage for acute cholangitis, evidence for optimal timing across severity grades remains limited. We examined associations between drainage timing and both functional and survival outcomes stratified by disease severity using the Tokyo Guidelines 2018 criteria. Methods: This retrospective observational cohort study included 214 consecutive patients with acute cholangitis who underwent endoscopic retrograde cholangiopancreatography between April 2022 and March 2024 at a tertiary center in Okinawa, Japan. Patients were classified according to the 2018 Tokyo Guidelines severity criteria. The primary outcome was discharge disposition (favorable: discharge to pre-admission residence; unfavorable: alternative facility or death). Time from presentation to drainage was analyzed at 12-, 24-, 36-, and 48-hour cutoffs using Fisher's exact test. Results: The cohort comprised 92 Grade I (43%), 83 Grade II (39%), and 39 Grade III (18%) patients. Discharge-to-pre-admission-residence rates were 95% (87/92), 80% (66/83), and 69% (27/39), respectively. For Grade I, drainage within 24 hours was associated with 100% (59/59) discharge to pre-admission residence versus 88% (28/32) beyond 24 hours (P = 0.013). Grade II showed no functional benefit but was associated with improved survival when drainage occurred within 48 hours (99% vs 82%, P = 0.045). Grade III survivors showed better functional recovery with drainage within 24 hours (92% vs 50%, P = 0.014), though this comparison included only 10 patients in the delayed group and should be interpreted with considerable caution. Conclusions: Associations between drainage timing and outcomes varied by severity grade and outcome type. Given the observational design and limited adjustment for confounders, these findings suggest severity-stratified drainage protocols may be beneficial but require validation through prospective studies with multivariable adjustment to establish causality.
- Open Access
- 6 November 2024
- Published by Springer Nature in Cureus
- Vol. 16 (11) , e73122
New-Onset Graves’ Disease Induced by COVID-19: A Case Report and Literature Review
We present a case of new-onset Graves' disease in a 40-year-old woman following COVID-19 infection. The patient experienced hand tremors, palpitations, shortness of breath with minimal exertion, and excessive sweating one week after recovering from COVID-19. Thyroid function tests revealed thyrotoxicosis, elevated free thyroxine, free triiodothyronine, and suppressed thyroid-stimulating hormone levels. Positive antithyroid peroxidase and thyroid-stimulating hormone (TSH) receptor antibodies, along with ultrasonography findings of diffuse thyroid enlargement and hypervascularization, confirmed the diagnosis of Graves' disease. Scintigraphy was omitted per the patient's request. This case contributes to the growing evidence suggesting SARS-CoV-2 may trigger autoimmune responses leading to thyroid disorders. We discuss the epidemiology, clinical characteristics, and potential mechanisms of Graves' disease following COVID-19, reviewing 28 similar cases reported from 2020 to early 2024. Our analysis reveals varied onset times and severity of thyroid dysfunction post-COVID-19, with some cases progressing to thyroid storm. Our findings highlight the importance of vigilant post-COVID-19 follow-up and contribute to understanding SARS-CoV-2's long-term consequences. From a cost-benefit perspective, a targeted screening approach might be needed for patients with persistent symptoms suggestive of thyroid dysfunction. This strategy could facilitate early detection and treatment, potentially preventing complications and reducing long-term healthcare costs.
- 6 November 2024
- Published by Springer Nature in Cureus
- Vol. 16 (11) , e73122
Open AccessNew-Onset Graves’ Disease Induced by COVID-19: A Case Report and Literature Review
We present a case of new-onset Graves' disease in a 40-year-old woman following COVID-19 infection. The patient experienced hand tremors, palpitations, shortness of breath with minimal exertion, and excessive sweating one week after recovering from COVID-19. Thyroid function tests revealed thyrotoxicosis, elevated free thyroxine, free triiodothyronine, and suppressed thyroid-stimulating hormone levels. Positive antithyroid peroxidase and thyroid-stimulating hormone (TSH) receptor antibodies, along with ultrasonography findings of diffuse thyroid enlargement and hypervascularization, confirmed the diagnosis of Graves' disease. Scintigraphy was omitted per the patient's request. This case contributes to the growing evidence suggesting SARS-CoV-2 may trigger autoimmune responses leading to thyroid disorders. We discuss the epidemiology, clinical characteristics, and potential mechanisms of Graves' disease following COVID-19, reviewing 28 similar cases reported from 2020 to early 2024. Our analysis reveals varied onset times and severity of thyroid dysfunction post-COVID-19, with some cases progressing to thyroid storm. Our findings highlight the importance of vigilant post-COVID-19 follow-up and contribute to understanding SARS-CoV-2's long-term consequences. From a cost-benefit perspective, a targeted screening approach might be needed for patients with persistent symptoms suggestive of thyroid dysfunction. This strategy could facilitate early detection and treatment, potentially preventing complications and reducing long-term healthcare costs.
- Open Access
- 11 June 2024
- Published by Springer Nature in Cureus
- Vol. 16 (6) , e62203
Subacute Thyroiditis Following COVID-19: A Case of Diagnostic Challenge in the Absence of Neck Pain
This case report presents a 77-year-old woman who developed subacute thyroiditis following COVID-19. The patient exhibited atypical symptoms, including fever, fatigue, anorexia, significant weight loss, headaches, and palpitations, without the typical neck pain or tenderness associated with thyroiditis. One week later, a follow-up examination showed mild enlargement and tenderness of the thyroid. Laboratory tests indicated elevated thyroid hormone levels and suppressed thyroid-stimulating hormone. Ultrasonography revealed diffuse thyroid enlargement with poor blood flow, consistent with subacute thyroiditis. Despite the absence of typical neck pain, the diagnosis was supported by clinical, laboratory, and imaging findings. This case suggests the importance of considering subacute thyroiditis as a potential secondary condition following COVID-19, even in the absence of typical symptoms. Clinicians should consider that and perform thorough evaluations in patients with recent COVID-19 exposure and nonspecific symptoms.
- 11 June 2024
- Published by Springer Nature in Cureus
- Vol. 16 (6) , e62203
Open AccessSubacute Thyroiditis Following COVID-19: A Case of Diagnostic Challenge in the Absence of Neck Pain
This case report presents a 77-year-old woman who developed subacute thyroiditis following COVID-19. The patient exhibited atypical symptoms, including fever, fatigue, anorexia, significant weight loss, headaches, and palpitations, without the typical neck pain or tenderness associated with thyroiditis. One week later, a follow-up examination showed mild enlargement and tenderness of the thyroid. Laboratory tests indicated elevated thyroid hormone levels and suppressed thyroid-stimulating hormone. Ultrasonography revealed diffuse thyroid enlargement with poor blood flow, consistent with subacute thyroiditis. Despite the absence of typical neck pain, the diagnosis was supported by clinical, laboratory, and imaging findings. This case suggests the importance of considering subacute thyroiditis as a potential secondary condition following COVID-19, even in the absence of typical symptoms. Clinicians should consider that and perform thorough evaluations in patients with recent COVID-19 exposure and nonspecific symptoms.
- 23 September 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 29 (1) , 78-81
Clostridium ramosum bacteremia: A case series at a general acute care hospital
- 23 September 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 29 (1) , 78-81
Clostridium ramosum bacteremia: A case series at a general acute care hospital
- Open Access
- 1 February 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 103, 42-47
Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia
- 1 February 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 103, 42-47
Open AccessEvaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia